Literature DB >> 15019638

Renal insufficiency and end-stage renal disease in the heart transplant population.

Jeffrey Rand Rubel1, Edgar Louis Milford, Dianne Brenda McKay, John Adams Jarcho.   

Abstract

BACKGROUND: Renal insufficiency and end-stage renal disease (ESRD) are important problems in the cardiac transplant population, and are associated with significant morbidity, mortality and financial cost. We undertook this study to define pre-operative or early post-operative predictors of subsequent renal insufficiency and ESRD.
METHODS: We studied 370 patients at Brigham and Women's Hospital who received heart transplants between 1984 and 1999, with up to 10-year follow-up. We evaluated 2 time-dependent primary outcomes: early reduction in GFR, and development of ESRD at any timepoint. Cox proportional hazards modeling was used in both univariate and multivariate analyses.
RESULTS: The mean estimated glomerular filtration rate (GFR) fell 24% within the first post-transplant year, and remained stable thereafter. By actuarial analysis, 23% of patients developed a 50% reduction in GFR by the third year, and 20% developed ESRD by the tenth year of follow-up. In Cox multivariate analysis, significant predictors of post-transplant ESRD included: GFR <50 ml/min (hazards ratio [HR] 3.69, p = 0.024); high mean cyclosporine trough in the first 6 months (HR 5.10, p = 0.0059); and presence of diabetes (HR 3.53, p = 0.021). Conclusions about renal insufficiency outcome were limited by difficulties with accurate estimation of GFR and with definition of renal insufficiency.
CONCLUSIONS: The results of this study underscore the magnitude of the problem of renal insufficiency and ESRD in the heart transplant population. In addition, these data suggest that patients at high risk for these outcomes can be identified early, even pre-operatively, to guide post-operative management.

Entities:  

Mesh:

Year:  2004        PMID: 15019638     DOI: 10.1016/S1053-2498(03)00191-8

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  9 in total

1.  Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus.

Authors:  Kristina I Rother; David M Harlan
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

Review 2.  Chronic renal insufficiency in heart transplant recipients: risk factors and management options.

Authors:  Francisco González-Vílchez; José Antonio Vázquez de Prada
Journal:  Drugs       Date:  2014-09       Impact factor: 9.546

3.  Predictors of rehospitalization time during the first year after heart transplant.

Authors:  Anne Jalowiec; Kathleen L Grady; Connie White-Williams
Journal:  Heart Lung       Date:  2008 Sep-Oct       Impact factor: 2.210

Review 4.  Postoperative care of the transplanted patient.

Authors:  Kurt R Schumacher; Robert J Gajarski
Journal:  Curr Cardiol Rev       Date:  2011-05

5.  Heart Retransplant Recipients Have Better Survival With Concurrent Kidney Transplant Than With Heart Retransplant Alone.

Authors:  Jill Savla; Kimberly Y Lin; Madhura Pradhan; Rebecca L Ruebner; Rachel S Rogers; Somaly S Haskins; Anjali T Owens; Peter Abt; J William Gaynor; Robert E Shaddy; Joseph W Rossano
Journal:  J Am Heart Assoc       Date:  2015-12-11       Impact factor: 5.501

Review 6.  Kidney disease in non-kidney solid organ transplantation.

Authors:  Kurtis J Swanson
Journal:  World J Transplant       Date:  2022-08-18

Review 7.  Chronic kidney disease after liver, cardiac, lung, heart-lung, and hematopoietic stem cell transplant.

Authors:  Sangeeta Hingorani
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

8.  Cellular effects of everolimus and sirolimus on podocytes.

Authors:  Sandra Müller-Krebs; Lena Weber; Julia Tsobaneli; Lars P Kihm; Jochen Reiser; Martin Zeier; Vedat Schwenger
Journal:  PLoS One       Date:  2013-11-15       Impact factor: 3.240

9.  Haemodynamic parameters associated with renal function prior to and following heart transplantation.

Authors:  Guillaume Baudry; Laurent Sebbag; Juliette Bourdin; Elisabeth Hugon-Vallet; Antoine Jobbe Duval; Nathan Mewton; Matteo Pozzi; Patrick Rossignol; Nicolas Girerd
Journal:  ESC Heart Fail       Date:  2021-09-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.